Invuity’s patented Intelligent Photonics™ devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced the closing of its public offering of 3,220,000 shares of its common stock at a price to the public of $10.00 per share, which includes the exercise in full by the underwriters of their option to purchase an additional 420,000 additional shares of common stock. The total net proceeds from the offering are estimated to be approximately $29.9 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Invuity. Piper Jaffray & Co. and Leerink Partners LLC acted as joint book-running...Read More
SAN FRANCISCO, July 28, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced the pricing of its public offering of 2.8 million shares of its common stock at a price to the public of $10.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 420,000 additional shares of its common stock. Piper Jaffray & Co. and Leerink Partners LLC are acting as joint book-running managers for the offering. William Blair & Company, L.L.C. is acting as a co-manager for the offering. The offering is being made pursuant to an effective shelf registration statement on For...Read More
SAN FRANCISCO, July 27, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading surgical photonics company, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Invuity expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. Invuity intends to use the net proceeds from the offering for continued expansion of its sales and marketing activities, investments in research and development, potential acquisitions or investments in complementary products, technologies or businesses, and working capital and other gen...Read More
“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
New York, NY
“Invuity’s Saber handheld illuminator with Frazier suction enables me to more efficiently achieve rapid hemostasis during cervical and lumbar spine surgery. I’m able to direct its light precisely where it is needed to quickly locate and control bleeders especially in far lateral recesses and deep surgical cavities. Since using the Eigr Saber I have seen a significant decrease in blood loss due to its superior illumination within the incision.”
Formerly Chief, Division of Spinal Surgery
Brigham and Women's Hospital
Assistant Professor of Surgery, Harvard Medical School
“Invuity’s Intelligent Photonics technology allows me to perform more minimally invasive spinal surgeries (MIS), including discectomies and fusions, with remarkable visualization. This is truly an enabling technology that allows me to expand my use of MIS and other advanced spine technologies, to the benefit of my patients.”
Chairman, Texas Back Institute Research Foundation